Loading institutional data...
Loading institutional data...
Held by 593 of 5,944 reporting institutions (97th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$141M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -5%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $377M covers all $193M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2022-01-29 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~3.3% on $729M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 59.1 | 58.3 | 58.3 | 68.3 | 67.9 | 60.4 | 61.2 | 74.7 |
| Gross Profit | 40.9 | 41.7 | 41.7 | 31.7 | 32.1 | 39.6 | 38.8 | 25.3 |
| R&D | 10.9 | 12.7 | 13.6 | 12.3 | 11.9 | 13.6 | 12.3 | 6.5 |
| SG&A | 19.2 | 16.2 | 17.1 | 21.6 | 24.4 | 16.0 | 19.3 | 22.4 |
| Operating Income | 10.8 | 12.8 | 11.0 | -2.2 | -33.1 | 10.0 | 5.0 | -15.7 |
| Income Tax | 1.5 | 1.6 | 0.1 | -2.3 | -2.7 | 0.3 | 0.1 | -1.2 |
| Net Income | 15.1 | 11.2 | 5.9 | -0.9 | -32.6 | 8.3 | 5.3 | -13.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AVAV: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.98B 100.0% | $820.6M 100.0% | $716.7M 100.0% | $540.5M 100.0% | $445.7M 100.0% | $394.9M 100.0% | $367.3M 100.0% | $314.3M 100.0% | $271.1M 100.0% | $228.9M 100.0% |
| Cost of Revenue | $1.48B 74.7% | $502.0M 61.2% | $432.8M 60.4% | $367.0M 67.9% | $304.5M 68.3% | $230.4M 58.3% | $214.2M 58.3% | $185.9M 59.1% | $162.2M 59.8% | $133.8M 58.4% |
| Cost of Products | — | — | — | — | — | — | — | — | $112.0M 41.3% | $89.0M 38.9% |
| Cost of Services | — | — | — | — | — | — | — | — | $50.2M 18.5% | $44.8M 19.6% |
| Gross Profit | $500.6M 25.3% | $318.6M 38.8% | $283.9M 39.6% | $173.5M 32.1% | $141.2M 31.7% | $164.6M 41.7% | $153.1M 41.7% | $128.4M 40.9% | $107.7M 39.7% | $96.9M 42.3% |
| Research & Development | $127.7M 6.5% | $100.7M 12.3% | $97.7M 13.6% | $64.3M 11.9% | $54.7M 12.3% | $53.8M 13.6% | $46.5M 12.7% | $34.2M 10.9% | $26.4M 9.8% | $28.5M 12.4% |
| Selling, General & Admin | $443.3M 22.4% | $158.8M 19.3% | $114.4M 16.0% | $131.9M 24.4% | $96.4M 21.6% | $67.5M 17.1% | $59.5M 16.2% | $60.3M 19.2% | $50.8M 18.8% | $47.6M 20.8% |
| Operating Income | -$311.0M -15.7% | $40.8M 5.0% | $71.8M 10.0% | -$178.7M -33.1% | -$9.9M -2.2% | $43.3M 11.0% | $47.1M 12.8% | $33.8M 10.8% | $30.4M 11.2% | $20.8M 9.1% |
| Interest Expense | $24.2M 1.2% | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | $18.6M 0.9% | — | — | — | — | — | $4.8M 1.3% | $4.7M 1.5% | $2.2M 0.8% | $1.6M 0.7% |
| Other Income (Expense), net | $11.0M 0.6% | $1.1M 0.1% | -$4.4M -0.6% | -$346K -0.1% | -$10.3M -2.3% | -$8.3M -2.1% | $707K 0.2% | $12.0M 3.8% | -$49K -0.0% | $172K 0.1% |
| Pretax Income | -$288.2M -14.6% | $44.5M 5.4% | $61.6M 8.6% | -$190.8M -35.3% | -$13.3M -3.0% | $23.9M 6.0% | $47.2M 12.8% | $46.5M 14.8% | $31.3M 11.6% | $22.4M 9.8% |
| Income Tax Expense | -$23.1M -1.2% | $882K 0.1% | $1.9M 0.3% | -$14.7M -2.7% | -$10.4M -2.3% | $539K 0.1% | $5.8M 1.6% | $4.6M 1.5% | $9.8M 3.6% | $4.8M 2.1% |
| Net Income | -$265.1M -13.4% | $43.6M 5.3% | $59.7M 8.3% | -$176.2M -32.6% | -$4.2M -0.9% | $23.3M 5.9% | $41.1M 11.2% | $47.4M 15.1% | $17.6M 6.5% | $13.1M 5.7% |
| Per Share | ||||||||||
| EPS (Basic) | $-5.40 | $1.56 | $2.19 | $-7.04 | $-0.17 | $0.97 | $1.73 | $2.00 | $0.76 | $0.57 |
| EPS (Diluted) | $-5.40 | $1.55 | $2.18 | $-7.04 | $-0.17 | $0.96 | $1.71 | $1.97 | $0.75 | $0.56 |
| Weighted Avg Shares (Basic) | 49.1M | 28.0M | 27.2M | 25.0M | 24.7M | 24.0M | 23.8M | 23.7M | 23.5M | 23.1M |
| Weighted Avg Shares (Diluted) | 49.1M | 28.2M | 27.3M | 25.0M | 24.7M | 24.4M | 24.1M | 24.1M | 23.8M | 23.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $28.75T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $364.2B | 41.6× | 29.1× | 5.4× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.2B | 38.4× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $264.2B | 39.7× | 18.8× | 3.0× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $204.4B | 81.4× | 41.0× | 2.3× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $181.0B | 36.2× | — | 4.0× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $174.3B | 47.1× | 31.1× | 5.4× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $166.7B | 23.4× | 16.0× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $154.3B | 38.1× | — | 5.6× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.9B | 28.2× | 16.2× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.0B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $117.9B | 33.9× | 26.6× | 5.9× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.7B | 25.0× | — | 5.0× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $97.3B | 23.3× | 17.1× | 1.9× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.0B | 32.5× | 23.2× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| PWR | $92.6B | 91.1× | 46.0× | 3.3× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| VRT | $91.6B | 70.2× | 43.4× | 8.9× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| JCI | $91.6B | 27.9× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $91.5B | 61.4× | 40.3× | 11.1× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $86.2B | 27.1× | 16.6× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.2B | 31.9× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $83.9B | 15.1× | 9.4× | 0.9× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $82.1B | 36.1× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $80.4B | 45.3× | 28.9× | 7.8× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| AVAV | $7.9B | — | — | 4.0× | 141% | 25.3% | -13.4% | -6.0% | -5.2% | -15.9× | 593 |
Peers = companies sharing AVAV's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.